Journal profile · PHARMACOLOGY & PHARMACY
International Journal of Clinical Pharmacy
ISSN 2210-7703 · eISSN 2210-7711 · Springer International Publishing · NETHERLANDS · 6 issues per year · Founded 1979
International Journal of Clinical Pharmacy: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.21; hybrid open access; APC about USD 4,190; median 87 days to acceptance (81 articles, last 24 months); community-reported acceptance: easy; 220 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
International Journal of Clinical Pharmacy is published by Springer International Publishing and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Medication Adherence and Compliance and Pharmacovigilance and Adverse Drug Reactions, together about 48% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Widely recognized journal of the International Collaboration of Pharmacy Journal Editors (ICPJE, https://www.icpje.org/) in comportment with the Granada Statements, International Journal of Clinical Pharmacy publishes high-quality, peer-reviewed content in health services research specifically as it relates to some aspect of the medication use process. The medication use process includes but is not limited to the prescribing, preparation, dispensing, administration, adherence to, evaluation, monitoring, and outcomes associated with legend or with over-the-counter medications, incorporating the concept of clinical pharmacy which aims to optimize utilization of medicines to achieve person-centered and public health goals. The medication use process includes attitudes, perspectives, knowledge, and behaviors of any actor in this process, including prescribers, pharmacists, pharmacy personnel, other health practitioners, patients, and caregivers. As such, the Granada Group journals often refer to “pharmacy” in their title or description, as these persons are central to medication use process; however, research articles reviews, and commentaries can refer to any person involved in this process, as well as any evaluation (e.g., pharmaceoepidemiological) of the drug products themselves or systems employed to optimize the use process.The Granada Group journals share certain commonalities and also goals to improve the medication use process and the outcomes emanating from this endeavor; however, each journal has an established niche and optimally suited for certain types of manuscripts. Further description of the aims and scopes of International Journal of Clinical Pharmacy follows below:The aim of the International Journal of Clinical Pharmacy is to provide a medium for the publication of articles in the broad field of clinical pharmacy and related subjects. The editors therefore welcome original contributions on the above-mentioned fields and especially on the following: Development, implementation and evaluation of clinical pharmacy services Efficacy, effectiveness, efficiency and safety of medicines and related medical devices Adherence Applied pharmacogenomics, pharmacogenetics and personalized medicine Clinical pharmacy and medicines related policy and guideline developments Clinical pharmacy related education, training and professional development Informatics and automation Information on medicines and related medical devices Medication management Pharmaceuti
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Derek StewartPublisher website
Editorial board by country: 9 in mainland China (about 14%); most named United Kingdom 12, Mainland China 9, Portugal 6, United States 5, Australia 5 (64 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Practices and Patient OutcomesMedicine30.1%
- Medication Adherence and ComplianceMedicine11.4%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics6.6%
- Patient Safety and Medication ErrorsHealth Professions6.4%
- Pharmaceutical studies and practicesMedicine6.4%
- Antibiotic Use and ResistanceImmunology and Microbiology5.6%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance4.8%
- Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.21LetPub ·
- Impact factor (publisher) 2025
- 3.2Publisher website ·
- 5-year impact factor (publisher) 2025
- 3Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 1.24LetPub ·
- h-index
- 52LetPub ·
- h-index
- 79OpenAlex ·
- i10-index
- 1,442OpenAlex ·
- 2-year mean citedness
- 3.51OpenAlex ·
- Self-citation rate
- 18.8%LetPub ·
- Share of gold OA articles
- 46.11%LetPub ·
Volume
- Articles per year
- 188LetPub ·
- Downloads per year (publisher) 2025
- 1,000,000Publisher website ·
Articles by year OpenAlex count · 2,808 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 152 | 152 | 56 |
| 2025 | 220 | 112 | 658 |
| 2024 | 177 | 90 | 1,212 |
| 2023 | 149 | 101 | 1,441 |
| 2022 | 160 | 95 | 2,187 |
| 2021 | 150 | 76 | 2,268 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
87 daysMedian, submission to acceptance · P25–P75 51 days – 126 days
- Acceptance to online
- median 30 days (81 articles)
- Submission to online
- median 118 days
- Sample
- 81 articles with submission and acceptance dates (208 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- Peer review
- Single anonymous peer review, Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,190 / EUR 3,190 / GBP 2,790 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,000 words
- Reference style
- Numbered, in order of citation
- Not considered
- Case reports
Article types accepted13, with length limits
- brief reportThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …main text ≤ 350 words · abstract ≤ 350 words
- brief reportsGive preliminary or limited results of original research Abstract (max 350 words) structured as Introduction, Aim, Method, Results, Conclusion. Main text (max 1…Length not stated
- case reportThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- commentConvey thoughts, considerations, opinions or discuss contemporary issues Abstract (max 350 words); unstructured. Main text (max 2000 words) with no specific str…Length not stated
- correspondenceThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- letterThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- method paperThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …main text ≤ 4,000 words
- opinionThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- original researchThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- original research articleThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
- reviewThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …main text ≤ 350 words · abstract ≤ 350 words
- reviewsWhile systematic reviews and scoping reviews are preferred, other forms of review (e.g., narrative) may be considered. Abstract (max 350 words) structured as In…Length not stated
- systematic reviewThe journal welcomes papers in the following categories: Case reports are not considered for publication. AII submissions (including Comment and, if necessary, …Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data Availability
Data availability statement required for original research Model summary
This journal encourages authors to provide an optional statement of data availability in their article. Data Availability Statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether …
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in International Journal of Clinical Pharmacy, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Case reports not accepted Model summary
Case reports are not considered for publication.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- NETHERLANDS
- Language
- English
- Frequency
- 6 issues per year
- Founded
- 1979
- ISSN
- 2210-7703
- Electronic ISSN
- 2210-7711
- Latest issue on the website
- Volume 48, Issue 5 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about International Journal of Clinical Pharmacy
What CAS zone is International Journal of Clinical Pharmacy in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Clinical Pharmacy is in Zone 3 of Medicine, and in Zone 3 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of Clinical Pharmacy?
The latest impact factor listed by LetPub is 3.21; CiteScore 5, h-index 79.
How long does peer review take at International Journal of Clinical Pharmacy?
Based on the dates recorded on 81 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 51–126 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of International Journal of Clinical Pharmacy?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,000 words; Reference style: Numbered, in order of citation. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of International Journal of Clinical Pharmacy based?
Of the 64 board members whose country the journal's board page names, 9 (about 14%) are in mainland China; the countries named most often are United Kingdom (12), Mainland China (9) and Portugal (6). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal of Clinical Pharmacy?
According to LetPub and DOAJ records, International Journal of Clinical Pharmacy is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is International Journal of Clinical Pharmacy open access, and what is the APC?
International Journal of Clinical Pharmacy is a hybrid journal. For open-access publication: APC about USD 4,190.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .